Department of Psychology, University of British Columbia, Vancouver, British Columbia, Canada.
Department of Psychology, Simon Fraser University, Burnaby, British Columbia, Canada.
BMC Neurol. 2024 Sep 28;24(1):363. doi: 10.1186/s12883-024-03861-3.
Maladaptive coping such as fear avoidance behavior can prolong recovery from mild traumatic brain injury (mTBI). Routine assessment of fear avoidance may improve management of mTBI. This study aimed to validate a single-item measure of fear avoidance to make its assessment more pragmatic. The present study is a secondary analysis of a clinical trial that involved adults with persistent post-concussion symptoms (N = 90, 63% female). Participants completed the single-item fear avoidance rating, a validated legacy measure of fear avoidance (Fear Avoidance Behavior after Traumatic Brain Injury; FAB-TBI), and measures of anxiety (General Anxiety Disorder-7), depression (Patient Health Questionnaire-9), post-concussion symptoms (Rivermead Postconcussion Symptoms Questionnaire), and disability (World Health Organization Disability Assessment Schedule 12.0). Questionnaires were completed twice, at baseline (mean 18.1 weeks post injury) and again 12-16 weeks later following study-delivered rehabilitation in addition to usual care. We analyzed the associations (Spearman's correlations) and agreement (weighted Kappa) between the single-item and FAB-TBI at baseline, posttreatment, individual FAB-TBI item scores, and the change in scores between baseline and posttreatment. In addition, we examined correlations between the single-item fear avoidance measure and related constructs, including anxiety, depression, post-concussion symptoms, and disability. The single-item fear avoidance measure correlated strongly with the FAB-TBI both at baseline and following treatment (ρ = 0.63 - 0.67, p < .001), and moderately with FAB-TBI item scores (ρ = 0.4 - 0.6). The correlation between the change in these scores from baseline to posttreatment was moderate (ρ = 0.45, p < .001). Agreement between the single-item fear avoidance measure and discretized FAB-TBI scores was moderate (κ = 0.45 - 0.51). Before and after treatment, the single-item fear avoidance measure correlated moderately with anxiety (ρ = 0.34), depression (ρ = 0.43), post-concussion symptoms (ρ = 0.50), and disability (ρ = 0.43). The FAB-TBI was more strongly correlated with these measures (ρ = 0.53 - 0.73). In summary, the present study supports the criterion validity of the single-item fear avoidance measure. This measure may be a useful screening and monitoring tool for patients with mTBI but is not a substitute for the FAB-TBI questionnaire.
适应不良的应对方式,如恐惧回避行为,可能会延长轻度创伤性脑损伤(mTBI)的恢复时间。对恐惧回避的常规评估可以改善 mTBI 的管理。本研究旨在验证一个恐惧回避的单项测量指标,使其评估更具实用性。本研究是一项涉及持续性脑震荡后症状成年人的临床试验的二次分析(N=90,63%为女性)。参与者完成了恐惧回避单项评定、经过验证的恐惧回避传统测量(创伤性脑损伤后恐惧回避行为量表;FAB-TBI)以及焦虑(广泛性焦虑障碍 7 项)、抑郁(患者健康问卷 9 项)、脑震荡后症状(Rivermead 脑震荡后症状问卷)和残疾(世界卫生组织残疾评估量表 12.0)的测量。问卷在基线时(损伤后平均 18.1 周)完成了两次,之后在研究提供的康复治疗后 12-16 周(除了常规护理)又完成了两次。我们分析了单项恐惧回避测量与基线时、治疗后、单个 FAB-TBI 项目评分以及基线和治疗后评分变化之间的相关性(Spearman 相关系数)和一致性(加权 Kappa)。此外,我们还研究了单项恐惧回避测量与相关结构之间的相关性,包括焦虑、抑郁、脑震荡后症状和残疾。单项恐惧回避测量在基线和治疗后与 FAB-TBI 相关性均很强(ρ=0.63-0.67,p<0.001),与 FAB-TBI 项目评分中度相关(ρ=0.4-0.6)。这些评分从基线到治疗后变化之间的相关性为中度(ρ=0.45,p<0.001)。单项恐惧回避测量与离散化 FAB-TBI 评分之间的一致性为中度(κ=0.45-0.51)。在治疗前后,单项恐惧回避测量与焦虑(ρ=0.34)、抑郁(ρ=0.43)、脑震荡后症状(ρ=0.50)和残疾(ρ=0.43)中度相关。FAB-TBI 与这些测量指标的相关性更强(ρ=0.53-0.73)。总之,本研究支持单项恐惧回避测量的标准效度。该测量可能是 mTBI 患者有用的筛查和监测工具,但不能替代 FAB-TBI 问卷。